GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CardioComm Solutions Inc (OTCPK:EKGGF) » Definitions » EBITDA Margin %

CardioComm Solutions (CardioComm Solutions) EBITDA Margin % : 4.62% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CardioComm Solutions EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CardioComm Solutions's EBITDA for the three months ended in Dec. 2023 was $0.01 Mil. CardioComm Solutions's Revenue for the three months ended in Dec. 2023 was $0.13 Mil. Therefore, CardioComm Solutions's EBITDA margin for the quarter that ended in Dec. 2023 was 4.62%.


CardioComm Solutions EBITDA Margin % Historical Data

The historical data trend for CardioComm Solutions's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioComm Solutions EBITDA Margin % Chart

CardioComm Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -111.30 2.45 8.61 5.18 -5.05

CardioComm Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.00 -7.33 -4.93 -9.68 4.62

Competitive Comparison of CardioComm Solutions's EBITDA Margin %

For the Health Information Services subindustry, CardioComm Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioComm Solutions's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CardioComm Solutions's EBITDA Margin % falls into.



CardioComm Solutions EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CardioComm Solutions's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.033/0.653
=-5.05 %

CardioComm Solutions's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=0.006/0.13
=4.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioComm Solutions  (OTCPK:EKGGF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


CardioComm Solutions EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CardioComm Solutions's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioComm Solutions (CardioComm Solutions) Business Description

Traded in Other Exchanges
Address
18 Wynford Drive, Suite 305, North York, ON, CAN, M3C 3S2
CardioComm Solutions Inc develops advanced software, hardware and core laboratory reading services related to the electrocardiogram ("ECG") and ambulatory arrhythmia monitoring systems for medical and consumer markets. It engages in the provision of management software solutions. It specializes in software engineering of computer-based electrocardiogram management and reporting software. The company's products include software, Gems Win, Global ECG Management System, GlobalCardio 12 lead; hardware, include handheld ECG monitor; Asp Services, include ECG management service and smart monitoring; software modules, consists of Win Air, Auto attendant, HL7 interface and EMR integration; and other products, include ECG viewer SDK and QRS 12 lead universal.